Skip to Main Content

Paper Details

Neddylation inhibition sensitises renal medullary carcinoma tumours to platinum chemotherapy.
Clin Transl Med
4
2023
ERCC1, FANCD2, PDX, RMC, RMC cell, RMC cell lines, Renal medullary carcinoma, cancer, carboplatin, humans, p53, patient, pevonedistat, platinum, platinum salts, renal medullary carcinoma tumours, tumour
Author NameAffiliation
Timothy P HeffernanInstitute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center
Timothy P HeffernanThe University of Texas MD Anderson Cancer Center
Pavlos MsaouelCenter for Precision Environmental Health, Baylor College of Medicine
Pavlos MsaouelThe University of Texas MD Anderson Cancer Center
Pavlos MsaouelDavid H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center
Pavlos MsaouelThe University of Texas MD Anderson Cancer Center
  • 1 - 6

Datasets

Release 1.2